Ignite Creation Date:
2024-05-05 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00535912
Status:
COMPLETED
Last Update Posted:
2007-11-01
First Post:
2007-09-26
Brief Title:
Phase III Study Treatment of CLL B and C
Sponsor:
French Innovative Leukemia Organisation
Organization:
French Innovative Leukemia Organisation
Organization Data
Organization:
French Innovative Leukemia Organisation
Class:
OTHER
Study ID:
LLC 98
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
French Innovative Leukemia Organisation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None